Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- Check3 days agoNo Change Detected
- Check9 days agoChange DetectedAccess to the study record is blocked by a 403 error, replacing the detailed study information with a simple error page.SummaryDifference20%

- Check16 days agoChange DetectedNo additions or deletions were provided in the changes data. As a result, there are no changes to describe for this page context.SummaryDifference0.1%

- Check23 days agoChange DetectedNo additions or deletions are present in the provided changes, so the study page text remains unchanged according to the input.SummaryDifference0.1%

- Check30 days agoChange DetectedA funding attribution line '2017 ( U.S. NIH Grant/Contract )' was added to the study's official title area. The site revision was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check37 days agoChange DetectedNo additions or deletions were reported for this page. Therefore, the page content remains as currently shown in the Study Details section.SummaryDifference0.0%

- Check44 days agoChange DetectedNo text changes were detected in the supplied data. The study page content remains unchanged.SummaryDifference0.0%

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.